Traws Pharma, Inc. (TRAW) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.58M | -2.76M | -5.98M | -4.04M | -9.85M | -4.43M | -4.49M | -3.88M | -4.21M | -4.26M | -4.31M | -5.47M |
| Operating CF Margin % | - | - | -218.77% | -7087.72% | -17592.86% | -3920.35% | -3973.45% | -3437.17% | -3729.2% | -3774.34% | -3811.5% | -4445.53% |
| Operating CF Growth % | 56.92% | 31.73% | 39.31% | 8.8% | -119.42% | -14.06% | -6.55% | 8.93% | 2.16% | 22% | 19.96% | -2.01% |
| Net Income | -7.11M | -7.44M | -625K | 81.93M | -123.14M | -4.18M | -4.25M | -5.42M | -4.02M | -3.76M | -4.23M | -6.43M |
| Depreciation & Amortization | 44M | 44K | 1K | 2K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
| Stock-Based Compensation | 634M | 327K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -677.16M | 89K | -331K | -87.08M | 117.84M | 332K | 273K | 330K | 241K | 261K | -367K | 239K |
| Working Capital Changes | 3.69M | 4.22M | -5.02M | 1.11M | -4.56M | -582K | -517K | 1.2M | -435K | -766K | 287K | 718K |
| Change in Receivables | 2.11M | -1.8M | 331K | 356K | 0 | 0 | 0 | -1K | -1K | 1K | 11K | 9K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.01M | 2.47M | -3M | 793K | -394K | -529K | 175K | 100K | -119K | -1.29M | 302K | -892K |
| Cash from Investing | 0 | 0 | 0 | 0 | -3.65M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | 12.39% | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | -3.65M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.9M | 158K | 3.1M | 19.98M | 14M | 0 | 0 | 0 | 0 | -35K | 7K | 279K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1.9M | 2.1M | 6.51M | 19.98M | 14M | 0 | 0 | 0 | 0 | 19.89M | 35.15M | 3M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -1.94M | -3.42M | 0 | 0 | 0 | 0 | 0 | 0 | -19.93M | -35.15M | -2.72M |
| Net Change in Cash | -687K | -2.6M | -2.86M | 15.93M | 496K | -4.42M | -4.49M | -3.86M | -4.23M | -4.31M | -4.3M | -5.17M |
| Free Cash Flow | -2.58B | -2.76M | -5.98M | -4.04M | -9.85M | -4.43M | -4.49M | -3.88M | -4.21M | -4.26M | -4.31M | -5.47M |
| FCF Margin % | - | - | -218.77% | -7087.72% | -17592.86% | -3920.35% | -3973.45% | -3437.17% | -3729.2% | -3774.34% | -3811.5% | -4445.53% |
| FCF Growth % | -42984.13% | 31.73% | 39.31% | 8.8% | -119.42% | -14.06% | -6.55% | 8.93% | 2.16% | 22% | 20.18% | -2.03% |
| FCF per Share | -242.09 | -0.33 | -1.03 | -4.20 | -11.70 | -5.27 | -5.35 | -4.64 | -5.04 | -5.10 | -6.82 | -11.03 |
| FCF Conversion (FCF/Net Income) | 0.36x | 0.37x | 6.53x | 0.48x | 1.98x | 0.50x | 0.45x | 0.36x | 0.52x | 0.59x | 0.48x | 0.43x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |